🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 7 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/11/1996 | 38,65 | 38,65 | 37,87 | 37,99 | -1,70% | 2,01% | 5.363.664 |
| 11/11/1996 | 38,59 | 39,00 | 38,41 | 38,65 | +0,62% | 1,55% | 4.248.592 |
| 08/11/1996 | 37,87 | 38,76 | 37,75 | 38,41 | +1,58% | 2,68% | 6.842.392 |
| 07/11/1996 | 37,45 | 38,17 | 37,27 | 37,81 | +0,32% | 2,39% | 6.110.888 |
| 06/11/1996 | 36,38 | 37,81 | 36,38 | 37,69 | +4,64% | 3,93% | 8.701.754 |
| 05/11/1996 | 36,08 | 36,50 | 36,02 | 36,02 | +0,17% | 1,32% | 6.201.645 |
| 04/11/1996 | 35,13 | 36,14 | 35,13 | 35,96 | +1,86% | 2,89% | 6.085.526 |
| 01/11/1996 | 35,42 | 35,72 | 35,19 | 35,31 | +0,17% | 1,52% | 5.443.102 |
| 31/10/1996 | 34,83 | 35,48 | 34,71 | 35,25 | +0,68% | 2,23% | 4.170.411 |
| 30/10/1996 | 35,42 | 35,48 | 34,83 | 35,01 | -0,68% | 1,85% | 3.295.541 |
| 29/10/1996 | 34,89 | 35,37 | 34,47 | 35,25 | +1,37% | 2,56% | 5.571.587 |
| 28/10/1996 | 35,01 | 35,19 | 34,71 | 34,77 | -0,51% | 1,36% | 4.654.168 |
| 25/10/1996 | 35,78 | 35,84 | 34,95 | 34,95 | -2,50% | 2,50% | 4.639.915 |
| 24/10/1996 | 36,20 | 36,44 | 35,84 | 35,84 | -0,99% | 1,65% | 3.786.634 |
| 23/10/1996 | 35,96 | 36,26 | 35,84 | 36,20 | +0,33% | 1,16% | 5.286.531 |
| 22/10/1996 | 35,54 | 36,20 | 35,54 | 36,08 | +0,83% | 1,85% | 4.134.989 |
| 21/10/1996 | 35,90 | 36,26 | 35,66 | 35,78 | -0,50% | 1,66% | 5.236.437 |
| 18/10/1996 | 35,78 | 36,38 | 35,60 | 35,96 | +0,67% | 2,17% | 8.156.584 |
| 17/10/1996 | 34,65 | 35,78 | 34,65 | 35,72 | +3,99% | 3,27% | 10.432.421 |
| 16/10/1996 | 34,11 | 34,41 | 33,87 | 34,35 | +1,05% | 1,57% | 6.621.474 |
| 15/10/1996 | 34,35 | 34,41 | 33,58 | 33,99 | -0,52% | 2,43% | 5.293.238 |
| 14/10/1996 | 33,40 | 34,29 | 33,40 | 34,17 | +2,50% | 2,68% | 3.924.131 |
| 11/10/1996 | 33,22 | 33,58 | 32,98 | 33,34 | +0,36% | 1,80% | 2.754.773 |
| 10/10/1996 | 33,52 | 33,70 | 33,16 | 33,22 | -1,24% | 1,60% | 2.847.206 |
| 09/10/1996 | 33,99 | 34,05 | 33,64 | 33,64 | -1,40% | 1,23% | 3.078.814 |
| 08/10/1996 | 33,46 | 34,41 | 33,22 | 34,11 | +1,60% | 3,57% | 5.993.302 |
| 07/10/1996 | 33,93 | 33,99 | 33,58 | 33,58 | -1,23% | 1,23% | 3.031.654 |
| 04/10/1996 | 33,93 | 34,29 | 33,93 | 33,99 | +0,00% | 1,05% | 4.038.363 |
| 03/10/1996 | 33,64 | 33,99 | 33,46 | 33,99 | +1,06% | 1,60% | 4.247.334 |
| 02/10/1996 | 34,05 | 34,17 | 33,58 | 33,64 | -0,70% | 1,75% | 4.081.541 |